

Cover Story
Capitol HillFree
After taking eight months to respond to a House committee’s questions about policies on handling of sexual misconduct cases, a letter from NIH has provided answers that critics describe as vague and inadequate.
In Brief


Clinical Roundup


Drugs & Targets
Trending Stories
- UCSD’s Comprehensive Cancer Center designation is in trouble; director Califano steps down amid turmoil
- Richard Pazdur discusses root causes of cisplatin and carboplatin shortage and what can be done to alleviate it
- Robert Winn tells us how he led VCU Massey to obtain Comprehensive designation
- Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die
- Sexual harassers should face consequences: As NIH director, Bertagnolli can foster change
- Ezra Cohen named chief medical officer of oncology at Tempus